CN114480532A - 菌株ch18在制备花青素与其它黄酮类化合物中的应用 - Google Patents
菌株ch18在制备花青素与其它黄酮类化合物中的应用 Download PDFInfo
- Publication number
- CN114480532A CN114480532A CN202210094359.4A CN202210094359A CN114480532A CN 114480532 A CN114480532 A CN 114480532A CN 202210094359 A CN202210094359 A CN 202210094359A CN 114480532 A CN114480532 A CN 114480532A
- Authority
- CN
- China
- Prior art keywords
- strain
- glucoside
- anthocyanin
- product
- pelargonidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930003935 flavonoid Natural products 0.000 title claims abstract description 58
- 235000017173 flavonoids Nutrition 0.000 title claims abstract description 58
- 229930002877 anthocyanin Natural products 0.000 title claims abstract description 54
- 235000010208 anthocyanin Nutrition 0.000 title claims abstract description 54
- 239000004410 anthocyanin Substances 0.000 title claims abstract description 54
- 150000004636 anthocyanins Chemical class 0.000 title claims abstract description 52
- -1 flavonoid compounds Chemical class 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 36
- 239000000126 substance Substances 0.000 claims abstract description 29
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 18
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 18
- 238000004321 preservation Methods 0.000 claims abstract description 12
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003944 flavone Natural products 0.000 claims abstract description 8
- 235000011949 flavones Nutrition 0.000 claims abstract description 8
- 239000008280 blood Substances 0.000 claims abstract description 4
- 210000004369 blood Anatomy 0.000 claims abstract description 4
- 230000036772 blood pressure Effects 0.000 claims abstract description 4
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims description 27
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 claims description 20
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 claims description 20
- 239000000049 pigment Substances 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 17
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 claims description 15
- 235000007336 cyanidin Nutrition 0.000 claims description 15
- 235000007242 delphinidin Nutrition 0.000 claims description 15
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 claims description 15
- 235000006251 pelargonidin Nutrition 0.000 claims description 15
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 14
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 14
- 229930182478 glucoside Natural products 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 229930003949 flavanone Natural products 0.000 claims description 12
- 235000011981 flavanones Nutrition 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 11
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 claims description 11
- PADQINQHPQKXNL-LSDHHAIUSA-N (+)-dihydrokaempferol Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C=C1 PADQINQHPQKXNL-LSDHHAIUSA-N 0.000 claims description 10
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 10
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 10
- RAYJUFCFJUVJBB-UHFFFAOYSA-N dihydrokaempferol Natural products OC1Oc2c(O)cc(O)cc2C(=O)C1c3ccc(O)cc3 RAYJUFCFJUVJBB-UHFFFAOYSA-N 0.000 claims description 10
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 claims description 10
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 claims description 10
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 10
- 235000009584 malvidin Nutrition 0.000 claims description 10
- 229920002414 procyanidin Polymers 0.000 claims description 10
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 9
- 241000207748 Petunia Species 0.000 claims description 9
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 8
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims description 8
- XFZJEEAOWLFHDH-NFJBMHMQSA-N procyanidin B2 Chemical group C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 7
- 235000005513 chalcones Nutrition 0.000 claims description 7
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 7
- 235000011957 flavonols Nutrition 0.000 claims description 7
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 7
- 235000008696 isoflavones Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims description 6
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 claims description 6
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 claims description 6
- WUADCCWRTIWANL-UHFFFAOYSA-N biochanin A Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O WUADCCWRTIWANL-UHFFFAOYSA-N 0.000 claims description 6
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 claims description 6
- XHEFDIBZLJXQHF-UHFFFAOYSA-N fisetin Chemical compound C=1C(O)=CC=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 XHEFDIBZLJXQHF-UHFFFAOYSA-N 0.000 claims description 6
- 150000002207 flavanone derivatives Chemical class 0.000 claims description 6
- 150000002208 flavanones Chemical class 0.000 claims description 6
- 150000002216 flavonol derivatives Chemical class 0.000 claims description 6
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims description 6
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 claims description 6
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 claims description 6
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 claims description 6
- 235000010209 hesperetin Nutrition 0.000 claims description 6
- 229960001587 hesperetin Drugs 0.000 claims description 6
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 6
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 claims description 6
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 claims description 6
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 6
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 6
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 claims description 6
- 235000007625 naringenin Nutrition 0.000 claims description 6
- 229940117954 naringenin Drugs 0.000 claims description 6
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 6
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims description 6
- 229920000385 Procyanidin B1 Polymers 0.000 claims description 5
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 5
- 229930015721 peonidin Natural products 0.000 claims description 5
- 235000006404 peonidin Nutrition 0.000 claims description 5
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims description 5
- XFZJEEAOWLFHDH-UKWJTHFESA-N procyanidin B1 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UKWJTHFESA-N 0.000 claims description 5
- 241000223221 Fusarium oxysporum Species 0.000 claims description 4
- 229920002350 Procyanidin B2 Polymers 0.000 claims description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 150000001789 chalcones Chemical class 0.000 claims description 4
- 235000013365 dairy product Nutrition 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 235000013622 meat product Nutrition 0.000 claims description 4
- 235000005875 quercetin Nutrition 0.000 claims description 4
- 229960001285 quercetin Drugs 0.000 claims description 4
- 235000014101 wine Nutrition 0.000 claims description 4
- 229930013915 (+)-catechin Natural products 0.000 claims description 3
- 235000007219 (+)-catechin Nutrition 0.000 claims description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 3
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 3
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 3
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims description 3
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 claims description 3
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 claims description 3
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 claims description 3
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 claims description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 claims description 3
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 claims description 3
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 claims description 3
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 3
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 claims description 3
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 claims description 3
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 claims description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 3
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 claims description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 3
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 3
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 claims description 3
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 claims description 3
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 claims description 3
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims description 3
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims description 3
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 3
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 claims description 3
- XPMFXZDODDEKIK-UHFFFAOYSA-O Pelargonidin 3-sophoroside 5-glucoside Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(CO)OC1OC(C(=[O+]C1=CC(O)=C2)C=3C=CC(O)=CC=3)=CC1=C2OC1C(O)C(O)C(O)C(CO)O1 XPMFXZDODDEKIK-UHFFFAOYSA-O 0.000 claims description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 3
- XPMFXZDODDEKIK-GCMAJIBFSA-O Rubrobrassicin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1c(-c2ccc(O)cc2)[o+]c2c(c(O[C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)cc(O)c2)c1)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XPMFXZDODDEKIK-GCMAJIBFSA-O 0.000 claims description 3
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 claims description 3
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 claims description 3
- 235000009962 acacetin Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 3
- 235000008714 apigenin Nutrition 0.000 claims description 3
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 claims description 3
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims description 3
- 229940117893 apigenin Drugs 0.000 claims description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 3
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 claims description 3
- 229940015301 baicalein Drugs 0.000 claims description 3
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 3
- 229960003321 baicalin Drugs 0.000 claims description 3
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000015838 chrysin Nutrition 0.000 claims description 3
- 229940043370 chrysin Drugs 0.000 claims description 3
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 3
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 claims description 3
- BQQCUFJAUJKCKH-GOWHUIJJSA-N delphinidin-3-O-arabinoside Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC(O)=C(O)C(O)=C1 BQQCUFJAUJKCKH-GOWHUIJJSA-N 0.000 claims description 3
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 claims description 3
- 229960004352 diosmin Drugs 0.000 claims description 3
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 claims description 3
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 3
- 235000012734 epicatechin Nutrition 0.000 claims description 3
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 3
- 235000011990 fisetin Nutrition 0.000 claims description 3
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims description 3
- 235000006539 genistein Nutrition 0.000 claims description 3
- 229940045109 genistein Drugs 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 claims description 3
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 claims description 3
- 235000008466 glycitein Nutrition 0.000 claims description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 3
- 229940025878 hesperidin Drugs 0.000 claims description 3
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 claims description 3
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 3
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 3
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 claims description 3
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 claims description 3
- 235000008718 isoliquiritigenin Nutrition 0.000 claims description 3
- 235000008800 isorhamnetin Nutrition 0.000 claims description 3
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000008777 kaempferol Nutrition 0.000 claims description 3
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 claims description 3
- 235000009498 luteolin Nutrition 0.000 claims description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 3
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 3
- PXUQTDZNOHRWLI-OXUVVOBNSA-O malvidin 3-O-beta-D-glucoside Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 PXUQTDZNOHRWLI-OXUVVOBNSA-O 0.000 claims description 3
- 238000009629 microbiological culture Methods 0.000 claims description 3
- 235000007708 morin Nutrition 0.000 claims description 3
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 claims description 3
- 235000007743 myricetin Nutrition 0.000 claims description 3
- 229940116852 myricetin Drugs 0.000 claims description 3
- DCYOADKBABEMIQ-OWMUPTOHSA-N myricitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=C(O)C=2)OC2=CC(O)=CC(O)=C2C1=O DCYOADKBABEMIQ-OWMUPTOHSA-N 0.000 claims description 3
- DCYOADKBABEMIQ-FLCVNNLFSA-N myricitrin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2cc(O)c(O)c(O)c2)Oc2c(c(O)cc(O)c2)C1=O DCYOADKBABEMIQ-FLCVNNLFSA-N 0.000 claims description 3
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 claims description 3
- CAHGSEFWVUVGGL-UBNZBFALSA-N pelargonidin 3-O-beta-D-glucoside chloride Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C=C1 CAHGSEFWVUVGGL-UBNZBFALSA-N 0.000 claims description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 3
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 claims description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 3
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 claims description 3
- 235000005493 rutin Nutrition 0.000 claims description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 3
- 229960004555 rutoside Drugs 0.000 claims description 3
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims description 3
- 235000014899 silybin Nutrition 0.000 claims description 3
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 claims description 3
- 229960003232 troxerutin Drugs 0.000 claims description 3
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 claims description 3
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 claims description 3
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- SBBFXSBQYRSIPP-GNBUJSLZSA-O Cyanidin 3-O-arabinoside Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 SBBFXSBQYRSIPP-GNBUJSLZSA-O 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 229920002982 Procyanidin A2 Polymers 0.000 claims description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 claims description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- 210000003169 central nervous system Anatomy 0.000 claims description 2
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- NSEWTSAADLNHNH-UHFFFAOYSA-N pavetannin A-2 Natural products OC1CC2=C(O)C=C3OC(C4O)(C=5C=C(O)C(O)=CC=5)OC5=CC(O)=CC(O)=C5C4C3=C2OC1C1=CC=C(O)C(O)=C1 NSEWTSAADLNHNH-UHFFFAOYSA-N 0.000 claims description 2
- NSEWTSAADLNHNH-LSBOWGMISA-N proanthocyanidin A2 Chemical compound C1([C@H]2OC3=C4[C@H]5C6=C(O)C=C(O)C=C6O[C@]([C@@H]5O)(OC4=CC(O)=C3C[C@H]2O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 NSEWTSAADLNHNH-LSBOWGMISA-N 0.000 claims description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 claims description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 claims description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 claims description 2
- 229950000628 silibinin Drugs 0.000 claims description 2
- XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 claims 3
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 claims 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims 1
- 150000002206 flavan-3-ols Chemical class 0.000 claims 1
- 235000011987 flavanols Nutrition 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 235000021109 kimchi Nutrition 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 claims 1
- 239000012085 test solution Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 235000006708 antioxidants Nutrition 0.000 abstract description 7
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract description 7
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract description 6
- 150000002212 flavone derivatives Chemical class 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 244000005700 microbiome Species 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 208000001132 Osteoporosis Diseases 0.000 abstract description 2
- 230000002929 anti-fatigue Effects 0.000 abstract description 2
- 230000000259 anti-tumor effect Effects 0.000 abstract description 2
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000000955 neuroendocrine Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 43
- 238000001514 detection method Methods 0.000 description 24
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- 239000007789 gas Substances 0.000 description 13
- 150000002500 ions Chemical class 0.000 description 12
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 7
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 230000002194 synthesizing effect Effects 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000013375 chromatographic separation Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 239000002696 acid base indicator Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000007955 flavonoid glycosides Chemical group 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- WIBRYXRYDCWDBQ-UHFFFAOYSA-N 2-phenyl-2h-chromen-7-ol Chemical compound O1C2=CC(O)=CC=C2C=CC1C1=CC=CC=C1 WIBRYXRYDCWDBQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 229930182670 Astin Natural products 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 229930184616 taxin Natural products 0.000 description 1
- KOTXAHKUCAQPQA-AAUVPWARSA-N taxine Chemical compound C1([C@@H]([C@@H](O)C(=O)O[C@@H]2C=3/C[C@@](C([C@H](O)C4=C(C)[C@@H](OC(C)=O)CC(C4(C)C)[C@@H](OC(C)=O)\C=3)=O)(C)[C@@H](O)C2)N(C)C)=CC=CC=C1 KOTXAHKUCAQPQA-AAUVPWARSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/70—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor
- A23L13/72—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor using additives, e.g. by injection of solutions
- A23L13/74—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor using additives, e.g. by injection of solutions using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/20—Products from fruits or vegetables; Preparation or treatment thereof by pickling, e.g. sauerkraut or pickles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Birds (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Virology (AREA)
- Toxicology (AREA)
Abstract
本发明公开了菌株CH18在制备花青素与其它黄酮类化合物中的应用。所述菌株CH18的保藏号为CGMCC NO.14784。黄酮类化合物具有抗氧化、抗肿瘤、抗疲劳、延缓衰老、预防心脑血管疾病、降血压、降血脂、调节神经内分泌、抗骨质疏松症、祛斑抗皱、明目等作用。现有技术中的花青素等黄酮类化合物主要是从植物中获得,植物原料供给受季节性限制,且栽培需要占用大量的农田。本发明利用微生物生产花青素和其它黄酮物质具有廉价、易控制、生产周期短、可周年生产的优势,能够满足工业化生产的需要。因此,本发明为高效、低成本生产多种花青素与其它黄酮类化合物开辟了一条新的生物途径。
Description
技术领域
本发明属于微生物资源开发与利用技术领域,具体涉及菌株CH18在制备花青素与其它黄酮类化合物中的应用。
背景技术
花青素(anthocyanins)是一类重要的黄酮类化合物,是构成花朵和果实颜色的主要色素之一。根据其结构不同,可将植物中常见的花青素分为矢车菊色素、天竺葵色素、飞燕草色素、芍药色素、矮牵牛色素和锦葵色素等6类。黄酮类化合物是指以2-苯基色原酮为母核的一系列多酚类化合物,属于植物次生代谢产物。除花青素之外,黄酮类还包括黄酮醇、异黄酮、黄酮类、黄烷酮、查尔酮、双氢黄酮(醇)等不同类别物质。植物中黄酮类物质多以苷类形式存在,黄酮苷因所带羟基数、甲基化、乙酰化、糖基化数目、糖种类和连接位置等因素不同,形成种类繁多的黄酮苷类物质。现已查明在可食用的植物食品中有5000多种黄酮类化合物。不同植物来源的黄酮组分不同。
黄酮类化合物具有多种生物活性,如抗疲劳、抗菌、抗病毒、抗肿瘤、抗氧化自由基、抗炎、镇痛、保护肝脏、预防心脑血管疾病、降血压、降血脂、调节神经内分泌、抗骨质疏松症、祛斑抗皱、明目、提高机体免疫力、镇咳、祛痰、解痉等药理活性。
目前,花青素等黄酮类化合物主要来源于植物。植物生产周期长,且受环境、产地和原料供给季节性强等多重因素影响。与植物相比较,利用微生物生产花青素等黄酮类物质,具有生产周期短、低耗、高效、且可全年生产等优点,可满足工业化生产的需要,应用前景广阔。本发明筛选得到的菌株能够合成多种花青素和其它黄酮类化合物,为花青素等黄酮类化合物的生产开辟了一条生物新途径。
发明内容
本发明公开了菌株CH18在制备花青素类与其它黄酮类化合物中的应用,所述菌株CH18为尖孢镰刀菌(Fusarium oxysporum);该菌株2017年10月11日保藏在中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),保藏地址为北京市朝阳区北辰西路1号院3号,保藏号为CGMCC NO.14784;
本发明还公开了菌株CH18在制备生产花青素类与其他黄酮类化合物的产品中的应用,所述菌株CH18的保藏号为CGMCC NO.14784;
本发明还公开了菌株CH18在制备抗菌、抗病毒、增高白血球、抗肿瘤、降血压、降血脂、清除自由基或兴奋中枢神经系统的产品中的应用,所述菌株CH18的保藏号为CGMCCNO.14784;所述产品的生物活性物质为花青素类与其他黄酮类化合物;
优选的,所述花青素类为花青素或原花青素;
优选的,所述原花青素包括原花青素A和原花青素B;更优选的,原花青素A为原花青素A2;更优选的,所述原花青素B为原花青素B2;
优选的,所述花青素包括矢车菊色素(cyanindin)、天竺葵色素(pelargon idin)、飞燕草色素(delphinidin)、芍药色素(peonidin)、矮牵牛色素(pet unidin,Pt)和锦葵色素(malvidin)6类物质;
优选的,所述花青素包括矢车菊色素、天竺葵色素、飞燕草色素、芍药色素、矮牵牛色素、锦葵色素中的一类或多类;
优选的,所述的天竺葵色素包括天竺葵素、天竺葵素3槐糖苷5葡糖苷、天竺葵素-3,5-葡萄糖苷、天竺葵素-3-葡萄糖苷中的一种或多种;
优选的,所述的飞燕草色素包括飞燕草葡萄糖苷、飞燕草素-3-O-阿拉伯糖苷中的一种或多种;
优选的,所述的芍药色素包括芍药苷3-鼠李糖苷5-葡萄糖苷、芍药素葡萄糖苷、芍药色素-3-O-阿拉伯糖苷中的一种或多种;
优选的,所述的矮牵牛色素包括矮牵牛素葡萄糖苷、矮牵牛素3-O-阿拉伯糖;
优选的,所述的锦葵色素是指锦葵素-3-O-葡萄糖苷;
花青素类包括:原花青素和花青素;
本申请所述的原花青素为原花青素A和原花青素B
本申请所述的花青素的基本结构是3,5,7-羟基-2-苯基苯并吡喃;
优选的,所述黄酮类化合物为黄酮醇类、异黄酮类、黄烷酮类、黄酮类、查耳酮类、二氢黄酮(醇)类;
优选的,所述的黄酮醇类是指槲皮素、芦丁、杨梅苷、山奈素、曲克芦丁、淫羊藿苷、金丝桃苷、漆黄素、异鼠李素、紫云英苷、杨梅素、山奈酚、槲皮苷中的一种或多种,
优选的,所述的异黄酮类是指葛根素、染料木素、桑色素、大豆苷、染料木苷、鹰嘴豆芽素A、黄豆黄苷、黄豆黄素的一种或多种,
优选的,所述的黄烷酮(醇)类是指(+)-儿茶素、表没食子儿茶素没食子酸酯、表儿茶素中的一种或多种,
优选的,所述的查尔酮类是指根皮素、异甘草素的一种到多种,
优选的,所述的二氢黄酮(醇)是指水飞蓟宾、橙皮苷、花旗松素、新橙皮苷、落新妇苷、柚皮素、橙皮素、二氢槲皮素、二氢山奈酚、二氢杨梅素的一种或多种,
优选的,所述的黄酮类是指芹菜素、黄芩素、黄芩苷、木犀草素、地奥司明、白杨素、牡荆素、金合欢素、桔皮素的一种或多种;
优选的,所述产品为食品、保健品、医药、化妆品或日用化工产品;
优选的,所述食品为乳制品、肉制品、酒制品、含醇饮料、含酸饮料、面制品或泡菜;
优选的,所述保健品或所述医药或化妆品为菌粉、片制剂、胶囊制剂、膏状或液体制剂;
优选的,所述日用化工产品为酸碱pH测试液、测试粉、测试试纸、添加剂;
优选的,所述产品为食品、保健品、医药、化妆品或日用化工产品;
优选的,所述食品为乳制品、肉制品、酒制品、面制品或泡菜;
优选的,所述保健品或所述医药为菌粉、片制剂、胶囊制剂或液体制剂。
优选的,所述日用化工产品为添加剂;
靶向代谢组检测得到的柚皮素、二氢山奈酚、二氢杨梅素、二氢槲皮素、矢车菊素和天竺葵素等花青素合成的关键中间产物,揭示出菌株CH18合成花青素的3条途径,分别为二氢山奈酚(DHK)途径、二氢槲皮素(DHQ)途径和二氢杨梅素(DHM)途径。可应用于菌株CH18发酵生产花青素类化合物的调控和促进刺激。
本发明公开了一种菌株CH18或其发酵液在制备黄酮类化合物中的应用,所述黄酮成分包含多种花青素成分和45种其它黄酮类成分。所述菌株CH18的保藏号为CGMCCNO.14784;
有益效果在于:菌株CH18可以同时合成多种花青素和45种其它黄酮类物质,合成的黄酮类产量高,为微生物生产花青素和其它黄酮类复合产品和各种纯化产品提供了新资源和新途径。
现有黄酮类化合物主要是从植物中获得,植物原料供给受季节限制,而且栽培要占据大量的农田。利用菌株CH18生产,具有廉价、易控制、生产周期短、可以周年发酵生产等优势,可满足工业化生产的需要;因此,本发明为高效且低成本生产黄酮类化合物开辟了一条新的途径。菌株所产花青素可以应用于医疗保健、食品、化妆品、护发固发、环境水质检测、工农业等领域,应用前景广阔。
附图说明
图1为菌株CH18合成产物靶向测定总离子流图(TIC)
图2为LC-MS/MS靶向检测菌株CH18合成飞燕草-葡萄糖苷的色谱图;左图为对照品,右图为菌株CH18样品。
图3为菌株CH18合成产物LC-MS/MS测定总离子流图。
图4为LC-MS/MS检测菌株CH18合成芍药苷3-鼠李糖苷5-葡萄糖苷质谱图;
图5为菌株CH18发酵液在不同pH下的颜色变化,从左到右pH值依次为2、3、4、5、6、7、8、9、10、11。
图6为菌株CH18产花青素类物质对光的稳定性检测结果;
图7为金属离子对菌株CH18花青素提取液稳定性的影响;
图8-16为标准品及菌株CH18样中49种黄酮类物质的MRM图谱。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
菌株CH18于2017年10月11日保藏在中国微生物菌种保藏管理委员会普通微生物中心(简称CGMCC),保藏号为CGMCC NO.14784,保藏地址:北京市朝阳区北辰西路1号院3号,中国科学院微生物研究所。
实施例1菌株CH18发酵培养
将菌株CH18接种于无机盐液体培养基或PDA培养基中,在温度为22-30℃转速为160r/min-200r/min摇床中培养5d-20d,不同时间取样,用正丁醇溶剂提取并用0.22um或0.45um滤膜过滤,得到CH18待测样品,用于花青素和其它黄酮类成分测定。
所用的培养基配方如下:
PDA培养基:马铃薯200g,葡萄糖10-30g,蒸馏水1L,pH自然,115℃灭菌20-30min。固体培养基添加琼脂10g-15g。
无机盐培养基配制:磷酸氢二钾0.5g,磷酸二氢钾0.5g,氯化钠0.2g,硝酸铵2.0g,硫酸镁0.2g,氯化钙0.1g,硫酸锰0.01g,七水合硫酸亚铁0.01g,葡萄糖10-30g,蒸馏水1000mL,摇匀,115℃灭菌15-20min。
实施例2基于HPLC-MS/MS靶向代谢组检测菌株CH18合成黄酮类物质
1、材料与方法
(1)试剂
甲醇、乙腈均购自美国sigma公司色谱级试剂;甲酸购自上海阿拉丁生化科技股份有限公司。
标准品:柚皮素、二氢山奈酚、二氢杨梅素、二氢槲皮素、氯化天竺葵素、矢车菊素葡萄糖苷、飞燕草素葡萄糖苷和原花青素B2,购自于北京索莱宝科技有限公司,其它购于上海源叶生物科技有限公司。
(2)仪器
TGL-16高速冷冻离心机(湖南湘仪),涡旋振荡仪(湖南湘仪),
液相色谱Waters Acquity UPLC,质谱AB SCIEX 5500QQQ-MS
色谱柱:Acquity UPLC HSS T3(1.8μm,2.1mm*100mm)。
(3)样品处理
称取样本500μL置于2mL离心管内,冻干。然后将冻干后的样本加入0.400mL80%甲醇水(含内标200ng/mL),充分震荡1min,4℃超声30min;于4℃静置60min,离心10min,取上清液上机检测。
(4)UPLC-QQQ-MS方法
色谱分离条件:柱温:40℃;流动相组成:A-水(0.1%甲酸),B-乙腈,流速0.300mL/min。运行时间:18min,进样量:6μL。样本梯度洗脱程序见表1。
表1样本梯度洗脱程序
(5)质谱条件
电喷雾离子源(ESI离子源);多反应检测(Multiple Reaction Monitoring,MRM模式);气帘气(Curtain Gas):35arb;碰撞气(Collision GAS):7arb;离子喷雾电压(IonSprayvoltage):正负4500V;离子源温度(Temperature):450℃;离子源气体(IonSource Gas1):55arb;离子源气体(IonSource Gas2):55arb。
(6)MRM采集数据
将配制好的标准品溶液加入进样瓶中,进样。采用MRM方法采集数据。并对菌株CH18发酵样品中的黄酮产物进行质谱MRM检测。
2、菌株CH18合成黄酮类物质靶向代谢组检测结果
基于HPLC-MS/MS靶向代谢组检测菌株CH18发酵液中黄酮类产物,检测到了菌株合成黄酮类物质种类。菌株CH18样品检测总离子流图(TIC)见附图1。MRM采集参数与黄酮类成分检测结果见表2。标准品及CH18样品检测得到的49种黄酮产物的MRM图谱见图8-16。
表2 MRM采集参数与CH18产黄酮类物质检测结果
由表2可知,HPLC-MS/MS靶向代谢组检测得到了49种源于菌株CH18合成的黄酮类物质,其中有4种花青素类物质,分别为天竺葵素、矢车菊素、飞燕草素葡萄糖苷和原花青素B2,该结果填补了微生物代谢花青素成分研究空白。菌株CH18合成的飞燕草素葡萄糖苷的MRM色谱图见图2。
除了检测到菌株CH18合成花青素之外,同时检测到菌株CH18合成了其它黄酮类物质45种,它们分别属于黄酮醇类、异黄酮类、黄烷酮类、黄酮类、查耳酮类、二氢黄酮(醇)类6大类中的物质;其中的黄酮醇类是指槲皮素、芦丁、杨梅苷、山奈素、曲克芦丁、淫羊藿苷、金丝桃苷、漆黄素、异鼠李素、紫云英苷、杨梅素、山奈酚、槲皮苷中的一种或多种,所述的异黄酮类是指葛根素、染料木素、桑色素、大豆苷、染料木苷、鹰嘴豆芽素A、黄豆黄苷、黄豆黄素的一种或多种,所述的黄烷酮(醇)类是指(+)-儿茶素、表没食子儿茶素没食子酸酯、表儿茶素中的一种或多种,所述的查尔酮类是指根皮素、异甘草素的一种到多种,所述的二氢黄酮(醇)是指水飞蓟宾、橙皮苷、花旗松素、新橙皮苷、落新妇苷、柚皮素、橙皮素、二氢槲皮素、二氢山奈酚、二氢杨梅素的一种或多种,所述的黄酮类是指芹菜素、黄芩素、黄芩苷、木犀草素、地奥司明、白杨素、牡荆素、金合欢素、桔皮素的一种或多种。
另外,HPLC-MS/MS靶向代谢组检测得到的柚皮素、二氢山奈酚、二氢杨梅素、二氢槲皮素等物质,是菌株CH18合成花青素途径中的关键中间产物,通过解析得到了菌株CH18合成花青素的三条途径,分别为二氢山奈酚(DHK)途径、二氢槲皮素(DHQ)途径和二氢杨梅素(DHM)途径。可应用于菌株CH18发酵生产花青素类化合物的调控和促进刺激。
将靶向代谢组定量检测得到的菌株CH18合成的49种黄酮类物质的量相加,得到菌株CH18合成黄酮类物质含量。结果显示随着发酵培养基的不同和发酵时间不同,各种黄酮类物质的总含量将随之变化,总含量为3.38-104.80mg/L。
综上可知,菌株CH18可用于不同种类花青素与其它黄酮类成分的生产,也可用于多种黄酮类混合产物的生产。各种类产物可分别或混合用于医药、保健、食品、化妆品、pH显色指示剂、农业植物保护、工业有机制剂的抗氧化剂等领域。
实施例3 HPLC-MS/MS非靶向检测菌株CH18合成花青素类物质
1、HPLC-MS/MS非靶向检测CH18菌样方法
1)仪器与色谱分离条件:
仪器分析平台:LC-MS(Waters,UPLC;Thermo,Q Exactive),色谱柱:(ACQUITYUPLC HSS T3(2.1*100mm 1.8μm))
2)色谱分离条件:
柱温40℃;进样量:5μL;流速0.3mL/min;流动相组成A:水+0.05%甲酸,B:乙腈;流动相梯度洗脱程序见表3。
表3流动相洗脱程序
3)质谱检测参数:
正模式:加热器温度300°℃;鞘气流速:45arb;辅助气流速:15arb;尾气流速:1arb;电喷雾电压:3.0KV;毛细管温度:350℃;S-Lens RF Level,30%。
负模式:加热器温度300℃;鞘气流速:45arb;辅助气流速:15arb;尾气流速:1arb;电喷雾电压:3.2KV;毛细管温度:350℃;S-Lens RF Level,60%。
扫描模式:一级全扫描(Full Scan,m/z 70~1050)与数据依赖性二级质谱扫描(dd-MS2,TopN=10);分辨率:70,000(一级质谱)&17,500(二级质谱)。碰撞模式:高能量碰撞解离(HCD)。
2、菌株CH18产花青素种类检测结果
利用HPLC-MS/MS非靶向方法对菌株CH18发酵样中花青素类种类进行测定。菌株CH18样品检测总离子流图(TIC)见附图3。根据液质色谱联用检测得到的各组分的分子量和碎片物质的核质比m/z,对菌株CH18合成的花青素产物进行解析,初步鉴定得到菌株CH18合成花青素产物有6类,分别为矢车菊色素(cyanindin)、天竺葵色素(pelargonidin)、飞燕草色素(delphinidin)、芍药色素(peonidin)、矮牵牛色素(petunidin)和锦葵色素(malvidin),结果见表3。所述的矢车菊色素包括矢车菊素葡萄糖苷,矢车菊素-3-O-阿拉伯糖苷;所述的天竺葵色素包括天竺葵素3槐糖苷5葡糖苷、天竺葵素-3,5-葡萄糖苷、天竺葵素-3-葡萄糖苷;所述的飞燕草色素色素包括飞燕草素-3-O-阿拉伯糖苷;所述的芍药色素包括芍药苷3-鼠李糖苷5-葡萄糖苷、芍药素葡萄糖苷、芍药色素-3-O-阿拉伯糖苷;所述的矮牵牛色素包括矮牵牛素葡萄糖苷、矮牵牛素3-O-阿拉伯糖;所述的锦葵色素包括锦葵素-3-O-葡萄糖苷。以芍药苷3-鼠李糖苷5-葡萄糖苷为例,其测定质谱图见附图4。
表4花青素类物质检测结果
实施例4菌株CH18产花青素等黄酮类物质呈色与抗氧化性
1、菌株CH18产花青素类色素物质
将菌株CH18发酵液pH值分别调成pH2、3、4、5、6、7、8、9、10、11,发酵液呈现出不同颜色,见附图5,在酸性条件下为红色、碱性条件为蓝色到兰灰色。菌株CH18花青素作为呈色物质,可应用于与水质测定、体液测定、酸碱指示显色剂、食品、保健品、化妆品等领域。
在色素方面,随着人工合成色素大量使用引起的一系列环境和健康问题,增加了人们对天然色素的需求。天然色素主要来源于植物和微生物,植物生长周期长,在大规模应用中受限。与植物源天然色素相比,微生物源色素,例如CH18产生的花青素类色素,易于大规模快速发酵生产,具有广阔的应用前景。
2、菌株CH18产黄酮类物质的抗氧化性与稳定性测定
1)菌株CH18产黄酮类物质的抗氧化性
菌株CH18产黄酮类物质对DPPH自由基清除效果的测定:
取2mL菌株CH18提取液于试管中,加入0.25mmo l/L的1,1-二苯基-2-三硝基苯肼(DPPH)乙醇溶液2mL,混匀。室温静置30mi n,于517nm波长处测量吸光度,记为A1;取2mL菌株CH18提取液与2mL无水乙醇混合均匀,测量吸光度,记为A2;取2mL DPPH乙醇溶液与2mL无水乙醇溶液混合均匀,测量吸光度,记为A3。用维生素C(Vc)作为阳性对照。菌株CH18黄酮物质对DPPH自由基的清除率计算公式如下:
DPPH清除率(%)=[1-(A1-A2)÷A3]×100
研究发现,在VC添加量为0.08mg/ml和0.18mg/ml条件下,菌株CH18提取液中黄酮物质对DPPH除率率分别高于Vc溶液7.1%和5.5%。显示菌株CH18提取液对DPPH自由基具有较高的清除能力和抗氧化活性,可应用于食品、药品、保健品、化妆品等领域,也可作为抗氧化剂应用。
2)菌株CH18产花青素类物质的稳定性
a)光照与黑暗对稳定性影响
在室温(20℃-37℃)条件下,比较光照与黑暗对菌株CH18产花青素类物质稳定性影响。根据菌株CH18花青素类物质在505nm有吸收峰特点,测定菌株CH18花青素液在OD505变化值,判断其稳定性。测定结果见附图6。研究发现菌株CH18产花青素类物质在光、暗条件下稳定性均较好。可在自然光照条件下和黑暗条件下应用和保存。
b)金属离子对稳定性影响
在菌株CH18花青素提取液中添加Ca2+、Na+、K+、Mg2+、Fe+和Fe3+盐,放在冰箱5℃条件下,观测溶液OD505值及溶液颜色变化。测定结果见附图7,结果显示,添加金属离子Ca2+、Na+、Mg2+、Fe+和Fe3+离子实验组,其溶液OD505值等于或高于对照组,可见上述金属离子添加不会影响CH18花青素稳定性,有的还可提高花青素的稳定性。因此,菌株CH18花青素添加到含有上述金属的食品、保健品、药品、水体、化妆品及其它产品中,花青素的稳定性好。
实施例5菌株CH18在产业中的应用
1、食品、药品、保健品
1)食品领域应用:利用菌株CH18液体发酵或利用大米等原料外加其他辅料例如麸皮作为培养基进行固态发酵,得到液体和固体发酵产品,提取混合物或其中的单纯成分或直接作为花青素原料,添加或应用到果酱、果冻、酸性饮料或含醇饮料行业,也可应用于乳制品、肉制品、酒制品、面制品或泡菜等食品业。由于其较强的抗氧化性、稳定性和生物活性,有助于延长食品的保藏和提高其营养价值。
2)保健品、药品领域应用
菌株CH18合成花青素和其它黄酮类产物具有高的抗氧化性、稳定性和生物活性,可以应用于保健品、药品生产。
2、酸碱指示显色剂、天然色素和抗氧化剂应用
花青素在较宽的pH范围内均能保持鲜艳的红色、紫色或蓝色,且在酸性条件下具有良好的热稳定性,加之具有较强的抗氧化活性,作为天然色素、显色剂、酸碱指示剂、抗氧化剂应用于食品、保健品、化妆品、水质检测、日用品、化工等行业。
3、生物制剂
根据菌株CH18合成的产物,可以生产多成分组成的抗氧化生物制剂,也可以通过分离纯化方法得到花青素各种成分和其它黄酮成分纯品,作为生物制剂、天然色素、生物化学成分标品、食品添加剂、保健品胶囊、粉剂、片剂或液体产品原料或添加剂应用。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对上述实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (10)
1.菌株CH18在制备花青素类与其他黄酮类化合物中的应用;
所述菌株CH18为尖孢镰刀菌(Fusarium oxysporum);该菌株2017年10月11日保藏在中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),保藏地址为北京市朝阳区北辰西路1号院3号,保藏号为CGMCC NO.14784。
2.菌株CH18在制备生产花青素类与其他黄酮类化合物的产品中的应用;
所述菌株CH18的保藏号为CGMCC NO.14784。
3.菌株CH18在制备抗菌、抗病毒、增高白血球、抗肿瘤、降血压、降血脂、天然色素、清除自由基或兴奋中枢神经系统的产品中的应用,所述菌株CH18的保藏号为CGMCC NO.14784,其特征在于,所述产品的生物活性物质为花青素类与其他黄酮类化合物。
4.根据权利要求1-3任一项所述的应用,其特征在于,所述花青素类为花青素或原花青素。
优选的,所述原花青素包括原花青素A和原花青素B;更优选的,原花青素A为原花青素A2;更优选的,所述原花青素B为原花青素B2。
5.根据权利要求4所述的应用,其特征在于,所述花青素包括矢车菊色素、天竺葵色素、飞燕草色素、芍药色素、矮牵牛色素、锦葵色素中的一种或多种;
优选的,所述矢车菊色素包括矢车菊素、矢车菊素葡萄糖苷,矢车菊素-3-O-阿拉伯糖苷中的1种或多种;
优选的,所述天竺葵色素包括天竺葵素、天竺葵素3槐糖苷5葡糖苷、天竺葵素-3,5-葡萄糖苷、天竺葵素-3-葡萄糖苷中的1种或多种;
优选的,所述飞燕草色素包括飞燕草葡萄糖苷、飞燕草素-3-O-阿拉伯糖苷中的1种或多种;
优选的,所述芍药色素包括芍药苷3-鼠李糖苷5-葡萄糖苷、芍药素葡萄糖苷、芍药色素-3-O-阿拉伯糖苷中的1种或多种;
优选的,所述矮牵牛色素包括矮牵牛素葡萄糖苷或矮牵牛素3-O-阿拉伯糖;
优选的,所述锦葵色素是指锦葵素-3-O-葡萄糖苷。
6.根据权利要求1-3任一项所述的应用,其特征在于,所述其他黄酮类化合物属于黄酮醇类、异黄酮类、黄烷酮类、黄酮类、查耳酮类、二氢黄酮(醇)类中一种或多种;
优选的,所述黄酮醇类包括槲皮素、芦丁、杨梅苷、山奈素、曲克芦丁、淫羊藿苷、金丝桃苷、漆黄素、异鼠李素、紫云英苷、杨梅素、山奈酚、槲皮苷中的一种或多种;
优选的,所述异黄酮类包括葛根素、染料木素、桑色素、大豆苷、染料木苷、鹰嘴豆芽素A、黄豆黄苷、黄豆黄素的一种或多种;
优选的,所述黄烷酮(醇)类包括(+)-儿茶素、表没食子儿茶素没食子酸酯、表儿茶素中的一种或多种;
优选的,所述的查尔酮类包括根皮素、异甘草素的一种到多种;
优选的,所述二氢黄酮(醇)包括水飞蓟宾、橙皮苷、花旗松素、新橙皮苷、落新妇苷、柚皮素、橙皮素、二氢槲皮素、二氢山奈酚、二氢杨梅素的一种或多种;
优选的,所述黄酮类包括芹菜素、黄芩素、黄芩苷、木犀草素、地奥司明、白杨素、牡荆素、金合欢素、桔皮素的一种或多种。
7.根据权利要求3所述的应用,其特征在于,所述产品为食品、保健品、医药、化妆品或日用化工产品。
8.根据权利要求7所述的应用,其特征在于,所述食品为乳制品、肉制品、酒制品、含醇饮料、含酸饮料、面制品或泡菜。
9.根据权利要求7所述的应用,其特征在于,所述保健品或所述医药或化妆品或天然色素为菌粉、片制剂、胶囊制剂、膏状或液体制剂。
10.根据权利要求7所述的应用,其特征在于,所述日用化工产品为酸碱pH测试液、测试粉、测试试纸、添加剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210094359.4A CN114480532A (zh) | 2022-01-26 | 2022-01-26 | 菌株ch18在制备花青素与其它黄酮类化合物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210094359.4A CN114480532A (zh) | 2022-01-26 | 2022-01-26 | 菌株ch18在制备花青素与其它黄酮类化合物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114480532A true CN114480532A (zh) | 2022-05-13 |
Family
ID=81475717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210094359.4A Pending CN114480532A (zh) | 2022-01-26 | 2022-01-26 | 菌株ch18在制备花青素与其它黄酮类化合物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114480532A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060019334A1 (en) * | 2004-07-10 | 2006-01-26 | Mattheos Koffas | Production of flavonoids by recombinant microorganisms |
CN108823101A (zh) * | 2018-01-19 | 2018-11-16 | 北京理工大学 | 一株花青素产生菌株ch18及其应用 |
CN110305797A (zh) * | 2019-06-18 | 2019-10-08 | 北京理工大学 | 一株花青素产生菌株cj6及其应用 |
-
2022
- 2022-01-26 CN CN202210094359.4A patent/CN114480532A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060019334A1 (en) * | 2004-07-10 | 2006-01-26 | Mattheos Koffas | Production of flavonoids by recombinant microorganisms |
CN108823101A (zh) * | 2018-01-19 | 2018-11-16 | 北京理工大学 | 一株花青素产生菌株ch18及其应用 |
CN110305797A (zh) * | 2019-06-18 | 2019-10-08 | 北京理工大学 | 一株花青素产生菌株cj6及其应用 |
Non-Patent Citations (2)
Title |
---|
宋建辉等: "植物花青素生物合成及调控", 《分子植物育种》 * |
张须学: "《天然药物化学》", 30 September 2012, 西安交通大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lang et al. | Classification and antioxidant assays of polyphenols: A review | |
Cao et al. | Characterization of flavonoids from Dryopteris erythrosora and evaluation of their antioxidant, anticancer and acetylcholinesterase inhibition activities | |
Hollman | Bioavailability of flavonoids. | |
Griffiths et al. | Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro | |
Liu et al. | Stability and absorption of anthocyanins from blueberries subjected to a simulated digestion process | |
Harborne et al. | Anthocyanins and other flavonoids | |
Nagao et al. | Mutagenicities of 61 flavonoids and 11 related compounds | |
Macgregor et al. | Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium | |
Li et al. | Litchi flavonoids: isolation, identification and biological activity | |
Iwashina | The structure and distribution of the flavonoids in plants | |
Kim et al. | Changing soybean isoflavone composition and concentrations under two different storage conditions over three years | |
Chen et al. | Interaction of flavonoids and intestinal facilitated glucose transporters | |
Diab et al. | Antimicrobial screening of some Egyptian plants and active flavones from Lagerstroemia indica leaves | |
Manzoor et al. | Flavonoids: health benefits and their potential use in food systems | |
Dwivedi et al. | Molecular structure, biological functions, and metabolic regulation of flavonoids | |
Majhi | Discovery, development and design of anthocyanins-inspired anticancer agents: A comprehensive review | |
CN107530390A (zh) | 多药性作用植物生物活性物质 | |
Tava et al. | Chemical identification of specialized metabolites from sulla (Hedysarum coronarium L.) collected in southern Italy | |
Lachowicz-Wiśniewska et al. | Flowers and leaves extracts of Stachys palustris L. exhibit stronger anti-proliferative, antioxidant, anti-diabetic, and anti-obesity potencies than stems and roots due to more phenolic compounds as revealed by UPLC-PDA-ESI-TQD-MS/MS | |
Santos-Buelga et al. | Recent Advances in Polyphenol Research, Volume 2 | |
Liu et al. | Production of high antioxidant activity flavonoid monoglucosides from citrus flavanone with immobilised α‐L‐rhamnosidase in one step | |
Ulubelen et al. | Labiatae flavonoids and their bioactivity | |
Rafay et al. | Phytochemicals analysis and antimicrobial activities of Echinops echinatus from Cholistan Desert, Pakistan | |
Meena et al. | Bioavailability and nutritional analysis of flavonoids | |
Gonçalves et al. | A green method for anthocyanin extraction from Clitoria ternatea flowers cultivated in Southern Brazil: characterization, in vivo toxicity, and biological activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |